← Eichor
Study identifier: NCT06996171 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia

Condition: Primary Insomnia  ·  Sponsor: CMH Kharian Medical College

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersNo

About this study

Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.

This description comes directly from the study's public registry record.

Talk to the study team

Mushayada Irshad, MBBS, MPhil Pharmacology  ·  +923237088421  ·  mishy2360@gmail.com

Usman Nawaz, MBBS, MPhil, PhD Pharmacology  ·  +923335641664  ·  drusmannawaz@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

CMH Kharian Medical CollegeKharan, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06996171